Smith & Nephew plc PT Raised to GBX 780 at Goldman Sachs Group Inc. (SN.)
Goldman Sachs Group Inc. upped their price target on shares of Smith & Nephew plc (LON:SN.) from GBX 760 ($12.13) to GBX 780 ($12.45) in a research note issued on Tuesday, Stock Ratings Network.com reports. The firm currently has a “neutral” rating on the stock.
SN. has been the subject of a number of other recent research reports. Analysts at Deutsche Bank reiterated a “hold” rating on shares of Smith & Nephew plc in a research note to investors on Thursday, October 10th. They now have a GBX 650 ($10.38) price target on the stock. Separately, analysts at Credit Suisse reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note to investors on Tuesday, October 8th. They now have a GBX 775 ($12.37) price target on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note to investors on Tuesday, October 8th. They now have a GBX 740 ($11.81) price target on the stock. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have issued a buy rating to the company. Smith & Nephew plc presently has a consensus rating of “Hold” and a consensus target price of GBX 773.33 ($12.35).
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (LON:SN) and advanced wound management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.